-
-
-
-
-
-
-
Nurix (NRIX) PT Lowered to $12 at Leerink Partners
-
-
-
-
-
-
-
BTIG Reiterates Neutral Rating on Nurix (NRIX)
-
-
-
-
-
-
-
Nurix Therapeutics, Inc. (NRIX) Reports In-Line Q3 EPS
-
-
-
-
-
-
-
JPMorgan Takeaways on Nurix (NRIX) Q1 Earnings
-
-
-
-
-
-
-
Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
-
-
-
-
-
-
-
Nurix (NRIX) PT Lowered to $53 at H.C. Wainwright
-
-
-
-
-
-
-
Nurix Therapeutics (NRIX) Reports Q4 Results, Provides Corporate Update
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

